Relationship of colonization with vancomycin-resistant enterococci and risk of systemic infection in patients with cancer [12]

Madonna J. Matar; Amar Safdar; Kenneth V.I. Rolston

doi:10.1086/503675

Relationship of colonization with vancomycin-resistant enterococci and risk of systemic infection in patients with cancer [12]

Madonna J. Matar, Amar Safdar, Kenneth V.I. Rolston

Infectious Diseases, Infection Control, and Employee Health

Research output: Contribution to journal › Letter › peer-review

27 Scopus citations

Original language	English (US)
Pages (from-to)	1506-1507
Number of pages	2
Journal	Clinical Infectious Diseases
Volume	42
Issue number	10
DOIs	https://doi.org/10.1086/503675
State	Published - May 15 2006

ASJC Scopus subject areas

Microbiology (medical)
Infectious Diseases

Access to Document

10.1086/503675

Cite this

@article{9e2c29bc976147e4a80bf803a269d6c5,

title = "Relationship of colonization with vancomycin-resistant enterococci and risk of systemic infection in patients with cancer [12]",

author = "Matar, {Madonna J.} and Amar Safdar and Rolston, {Kenneth V.I.}",

note = "Funding Information: of the speakers{\textquoteright} bureaus of Merck, Cubist, and Bristol Myers Squibb. K.V.I.R. is a member of the speakers{\textquoteright} bureaus of Elan, Cubist, Pfizer, and Bristol My-ers Squibb and has received recent research funding from Elan and Cubist. M.J.M.: no conflicts.",

year = "2006",

month = may,

day = "15",

doi = "10.1086/503675",

language = "English (US)",

volume = "42",

pages = "1506--1507",

journal = "Clinical Infectious Diseases",

issn = "1058-4838",

publisher = "Oxford University Press",

number = "10",

}

TY - JOUR

T1 - Relationship of colonization with vancomycin-resistant enterococci and risk of systemic infection in patients with cancer [12]

AU - Matar, Madonna J.

AU - Safdar, Amar

AU - Rolston, Kenneth V.I.

N1 - Funding Information: of the speakers’ bureaus of Merck, Cubist, and Bristol Myers Squibb. K.V.I.R. is a member of the speakers’ bureaus of Elan, Cubist, Pfizer, and Bristol My-ers Squibb and has received recent research funding from Elan and Cubist. M.J.M.: no conflicts.

PY - 2006/5/15

Y1 - 2006/5/15

UR - http://www.scopus.com/inward/record.url?scp=33646444070&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33646444070&partnerID=8YFLogxK

U2 - 10.1086/503675

DO - 10.1086/503675

M3 - Letter

C2 - 16619176

AN - SCOPUS:33646444070

SN - 1058-4838

VL - 42

SP - 1506

EP - 1507

JO - Clinical Infectious Diseases

JF - Clinical Infectious Diseases

IS - 10

ER -

Relationship of colonization with vancomycin-resistant enterococci and risk of systemic infection in patients with cancer [12]

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this